Investment Rating - The investment rating for the company is "Buy" [4][10] Core Views - The company reported a revenue of 2.154 billion in H1 2025, representing a year-on-year increase of 10.29%, with a net profit attributable to shareholders of 332 million, up 0.38% year-on-year [1][4] - The growth in revenue is driven by the electronic materials and new energy materials sectors, with H1 gross margin at 38.30% and net margin at 17.39%, showing slight declines compared to the previous year [2][3] - The company is focusing on six major business segments, with strategic investments and acquisitions to enhance its capabilities in biomedical materials and international expansion [3] Summary by Sections Financial Performance - H1 2025 revenue was 21.54 billion, with Q2 revenue at 11.79 billion, showing a quarter-on-quarter increase of 20.97% [1][4] - The gross margin for H1 2025 was 38.30%, with a net margin of 17.39%, reflecting a decrease of 1.59 and 1.63 percentage points year-on-year respectively [2] Business Segments - Revenue from electronic materials, catalytic materials, biomedical materials, architectural ceramics, and new energy materials for H1 2025 was 344 million, 456 million, 438 million, 484 million, and 217 million respectively, with new energy materials showing the highest growth at 26.36% year-on-year [2][3] - The company has made significant advancements in biomedical materials, including the development of high-transparency zirconia powder, and has established a sales network overseas [3] Future Outlook - The company expects net profits attributable to shareholders to reach 774 million, 886 million, and 1.058 billion for the years 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 27.30, 23.85, and 19.97 [3][9]

Core Viewpoint - The company reported a revenue increase of 10.29% year-on-year for the first half of 2025, driven by growth in electronic materials and new energy materials sectors [1][2]. Financial Performance - The company achieved a total revenue of 2.154 billion yuan in H1 2025, with a net profit attributable to shareholders of 332 million yuan, reflecting a year-on-year increase of 0.38% [1]. - In Q2 2025, the company generated revenue of 1.179 billion yuan, showing a quarter-on-quarter increase of 20.97% [1]. - The overall gross margin and net margin for H1 2025 were 38.30% and 17.39%, respectively, with slight declines compared to the previous year [2]. Business Segments - The company’s revenue from various segments in H1 2025 included: electronic materials (344 million yuan, +23.65%), catalytic materials (456 million yuan, +12.34%), biomedical materials (438 million yuan, -0.11%), building ceramics (484 million yuan, +2.59%), and new energy materials (217 million yuan, +26.36%) [2]. - The gross margins for these segments were as follows: electronic materials (32.97%), catalytic materials (41.80%), biomedical materials (52.18%), building ceramics (37.42%), and new energy materials (21.19%) [2]. Strategic Developments - The company is focusing on the collaborative development of six major business segments, with a strategic emphasis on biomedical materials and international expansion [3]. - Recent strategic investments include acquiring Spident in South Korea and Dekema in Germany, enhancing the company’s presence in clinical materials and digital equipment [3]. - The company has developed a high-transparency zirconia powder for aesthetic applications, which has passed validation with multiple clients and is beginning to be supplied in batches [3]. - In the ceramics sector, the company’s subsidiary is a key supplier of ceramic shells for low-orbit satellites [3]. - The company is also advancing in the new energy materials sector, particularly in solid-state battery technologies, with various solid electrolyte products developed [3]. Investment Outlook - The company is expected to see net profits attributable to shareholders of 774 million yuan, 886 million yuan, and 1.058 billion yuan for the years 2025 to 2027, with corresponding price-to-earnings ratios of 27.30, 23.85, and 19.97 [3].